Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

News Conference News AHA 2024

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

Michael O'Riordan

November 18, 2024

Some Daylight for Vitamin D? New Analysis Hints at Small CVD Benefit

News Daily News

Some Daylight for Vitamin D? New Analysis Hints at Small CVD Benefit

Michael O'Riordan

June 30, 2023

Short-term Testosterone Use Doesn’t Spur CV Events: Meta-analysis

News Daily News

Short-term Testosterone Use Doesn’t Spur CV Events: Meta-analysis

June 10, 2022

Race, Income Remain Predictors of Acute MI Revascularization in Women

News Daily News

Race, Income Remain Predictors of Acute MI Revascularization in Women

Yael L. Maxwell

January 10, 2022

An Oral PCSK9 Inhibitor? Early Data Show Safety, Big LDL Drops

News Conference News AHA 2021

An Oral PCSK9 Inhibitor? Early Data Show Safety, Big LDL Drops

November 15, 2021

Cost-effectiveness Favors Anatomic Over Functional Testing for Stable Chest Pain

News Daily News

Cost-effectiveness Favors Anatomic Over Functional Testing for Stable Chest Pain

December 18, 2020

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

December 10, 2019

Implantable Cardiac Monitor May Reduce Delays to Hospital in High-Risk ACS

News Daily News

Implantable Cardiac Monitor May Reduce Delays to Hospital in High-Risk ACS

October 15, 2019

Recurrent Events Common Among Young Patients With CAD

News Daily News

Recurrent Events Common Among Young Patients With CAD

Michael O'Riordan

October 11, 2019

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

News Daily News

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Michael O'Riordan

August 26, 2019

Higher Risk of Intracranial Hemorrhage With Aspirin in Primary Prevention

News Daily News

Higher Risk of Intracranial Hemorrhage With Aspirin in Primary Prevention

Michael O'Riordan

May 20, 2019

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

News Daily News

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

October 12, 2018

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

News Daily News

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

Yael L. Maxwell

April 18, 2018

ACC 2018, Day Three: Gout, Hypertension, and Diabetes Dominate Opening Late Breaker

News Conference News ACC 2018

ACC 2018, Day Three: Gout, Hypertension, Diabetes, PFO Closure, DAPT, NOAC Reversal, and More

March 12, 2018

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

News Features

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

September 15, 2017

Genetic Study Supports Link Between Serum Calcium and CAD Risk

News Daily News

Genetic Study Supports Link Between Serum Calcium and CAD Risk

July 26, 2017

News Daily News

新指南提示要补钙

October 26, 2016

News Daily News

Nuevas Directrices Dan Luz Verde a los Suplementos de Calcio

October 26, 2016

News Daily News

New Guideline Gives the Greenlight to Calcium Supplements

October 26, 2016

News Daily News

Young Women Need Earlier Messaging on Physical Activity for Preventing Later CHD, Study Hints

Michael H. Wilson

July 26, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.